ContraFect Corporation CFRX
Set alert
0.05 USD 0.00 0.00%
As of Dec 5, 3:31 PM ET
0.0457 Day range 0.062
52-week range unavailable
- Open
- 0.06
- Prev close
- 0.05
- Mkt cap
- 0
- Vol
- 910.22K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0457
- High
- 0.062
- Earnings
- Nov 14, 2023
3M chart
Events in this range
- Aug 14, 2023Earnings: —; estimate -1.81; surprise —%
Signals (13)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 8, 2023 | 2 years ago |
| RSI: Oversold | Nov 1, 2023 | 3 years ago |
| RSI: Oversold | Oct 26, 2023 | 3 years ago |
| RSI: Oversold | Oct 23, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 20, 2023 | 3 years ago |
| RSI: Oversold | Oct 5, 2023 | 3 years ago |
| RSI: Oversold | Sep 25, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 21, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 15, 2023 | 3 years ago |
| RSI: Oversold | Sep 11, 2023 | 3 years ago |
| RSI: Oversold | Sep 6, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 1, 2023 | 3 years ago |
| RSI: Oversold | Aug 9, 2023 | 3 years ago |
Next earnings
Nov 14, 2023
Expected Nov 14, 2023. Consensus EPS estimate -0.66.
Financials — quick view
CFRX Revenue — quarterly 0
CFRX Net income — quarterly -7.57M
CFRX EPS — quarterly -1.94
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2023 | Sep 1, 2023 | -0.66 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | -1.81 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | -10.83 | — | — | — |
| Mar 31, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 14, 2022 | Sep 1, 2022 | -18.40 | — | — | — |
| Aug 15, 2022 | Jun 1, 2022 | -23.20 | — | — | — |
News
- Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Is ContraFect (CFRX) Stock Up 23% Today?
- ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
- Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
- Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
- ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370
- Stocks That Hit 52-Week Lows On Friday
Your note
Sign in to keep a note on CFRX — it syncs with the Stock Master app.